Delivery Order SPE2DE21D7020-SPE2D625F0BSK
- Not listed
- Boston Scientific Corp, a global medical technology company headquartered in Marlborough, Massachusetts, has been awarded a delivery order valued at $2,475.34 by the Defense Health Agency's Medical Supply Chain on September 12, 2025. This fixed-price delivery order with economic price adjustment provisions is scheduled for completion by September 19, 2025, and represents work to be performed at the company's facility in Marlborough, Massachusetts. The contract carries no set-aside designation,...
- Boston Scientific Corp, a global medical technology company headquartered in Marlborough, Massachusetts, has been awarded a delivery order valued at $11,312.43 by the Defense Health Agency's Medical Supply Chain program. The contract, awarded on August 14, 2025, with an ultimate completion date of August 21, 2025, utilizes fixed-price pricing with economic price adjustment. The delivery order is to be performed at Boston Scientific's facility in Marlborough, MA, and no small business set-aside...
- Boston Scientific Corp, a global medical technology company headquartered in Marlborough, Massachusetts, was awarded a delivery order valued at $6,118.95 by the Defense Health Agency's Medical Supply Chain on September 16, 2025. This fixed-price contract with economic price adjustment provisions has an ultimate completion date of September 23, 2025 and carries no set-aside designation, indicating open competition in the federal marketplace. The work will be performed at Boston Scientific's...
- Boston Scientific Corp, a major global medical technology company headquartered in Marlborough, Massachusetts, has been awarded a delivery order valued at $32,850 by the Defense Health Agency's Medical Supply Chain under contract 4569047952. This fixed-price delivery order with economic price adjustment terms carries an ultimate completion date of August 18, 2025, and was issued on August 11, 2025. The contract is not set-aside and represents Boston Scientific's continued role as a prime...
- Boston Scientific Corp, a leading global medical technology company headquartered in Marlborough, Massachusetts, was awarded a delivery order valued at $75,560 by the Defense Health Agency's Medical Supply Chain on August 20, 2025, with an ultimate completion date of September 10, 2025. This fixed-price contract with economic price adjustment provisions represents a non-competitive award with no small business set-aside. As the place of performance is Boston Scientific's headquarters location in...
- Boston Scientific Corp, a global medical technology company headquartered in Marlborough, Massachusetts, was awarded a delivery order valued at $6,593.05 by the Defense Health Agency's Medical Supply Chain on August 28, 2025. This fixed-price contract with economic price adjustment provisions is scheduled for completion by September 5, 2025, and will be performed at Boston Scientific's facility in Marlborough, MA. The award represents a continuation of Boston Scientific's role as a critical...
- Boston Scientific Corp, a global medical technology company headquartered in Marlborough, Massachusetts, was awarded a delivery order valued at $13,027.08 by the Defense Health Agency's Medical Supply Chain on August 4, 2025. The contract, which utilizes fixed-price pricing with economic price adjustment, is scheduled for completion by August 11, 2025. The award represents a non-set-aside competitive procurement, and the place of performance is Boston Scientific's facility in Marlborough, MA. As...
- Boston Scientific Corp, a global medical technology company headquartered in Marlborough, Massachusetts, has been awarded a delivery order valued at $5,093.05 by the Defense Health Agency's Medical Supply Chain division. The contract, awarded on September 5, 2025, with an ultimate completion date of September 12, 2025, employs a fixed-price with economic price adjustment pricing structure and is not designated as a set-aside contract. Performance will take place at Boston Scientific's facility...
- Boston Scientific Corp, a global medical technology company headquartered in Marlborough, Massachusetts, was awarded a delivery order valued at $8,795.18 by the Defense Health Agency's Medical Supply Chain on June 24, 2025. The contract employs fixed-price pricing with economic price adjustment terms and is scheduled for completion by July 1, 2025. The award is not set-aside and represents Boston Scientific's continued role as a prime contractor supplying advanced medical devices to federal...
- Boston Scientific Corp, headquartered in Marlborough, Massachusetts, has been awarded a delivery order valued at $6,063.45 for medical supply chain support through the Defense Health Agency's Medical Supply Chain. The contract, awarded on July 29, 2025, with an ultimate completion date of August 5, 2025, operates under a fixed-price structure with economic price adjustment provisions. This delivery order is not set aside for any specific business category, allowing Boston Scientific to compete...
- SPE2DE21D7020Indefinite Delivery Contract
- SPE2DE21D7020-SPE2D625F0BSKDelivery Order
Boston Scientific Corp, a leading global medical technology company headquartered in Marlborough, Massachusetts, has been awarded a delivery order valued at $5,050.68 by the Defense Health Agency's Medical Supply Chain program. The contract, issued on August 4, 2025, with an ultimate completion date of August 11, 2025, utilizes fixed-price pricing with economic price adjustment terms and carries no set-aside designation. The place of performance is Boston Scientific's facility in Marlborough, Massachusetts, aligning with the company's primary manufacturing and distribution operations for specialized medical devices. This delivery order represents one of numerous awards Boston Scientific has received through the Defense Health Agency's Medical Supply Chain procurement vehicle, under which the company serves as a prime contractor providing critical medical technologies to federal healthcare systems. Boston Scientific's extensive federal contract portfolio demonstrates its role as a comprehensive supplier of advanced medical devices, including cardiovascular intervention tools, diagnostic equipment, and specialized medical technologies. The company's established relationship with federal healthcare agencies and its demonstrated capability to deliver complex medical solutions underscore its strategic importance to the Department of Defense's healthcare supply chain operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.1k | 8/4/25 |